0001144204-18-035164.txt : 20180621 0001144204-18-035164.hdr.sgml : 20180621 20180621161743 ACCESSION NUMBER: 0001144204-18-035164 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: 06b FILED AS OF DATE: 20180621 DATE AS OF CHANGE: 20180621 EFFECTIVENESS DATE: 20180621 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Biostage, Inc. CENTRAL INDEX KEY: 0001563665 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 455210462 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-315136 FILM NUMBER: 18912037 BUSINESS ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 BUSINESS PHONE: (774) 233-7300 MAIL ADDRESS: STREET 1: 84 OCTOBER HILL ROAD STREET 2: SUITE 11 CITY: HOLLISTON STATE: MA ZIP: 01746 FORMER COMPANY: FORMER CONFORMED NAME: Harvard Apparatus Regenerative Technology, Inc. DATE OF NAME CHANGE: 20121204 D 1 primary_doc.xml X0708 D LIVE 0001563665 Biostage, Inc. 84 OCTOBER HILL ROAD SUITE 11 HOLLISTON MA MASSACHUSETTS 01746 (774) 233-7300 DELAWARE None Harvard Apparatus Regenerative Technology, Inc. Corporation true James McGorry 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Executive Officer Director President and CEO Thomas McNaughton 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Executive Officer Chief Financial Officer Jing Chen 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Wei Zhang 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Hong Yu 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Executive Officer James Shmerling 84 October Hill Road, Suite 11 Holliston MA MASSACHUSETTS 01746 Director Biotechnology Decline to Disclose 06b false 2018-05-29 false true false 0 3600000 3600000 0 false 2 0 216000 This represents a financial advisory fee pursuant to this offering, payable over a term of 24 months. 0 Some of the proceeds may be used for working capital and other general corporate purposes, which may include the payment of salaries and other fees to those listed in Item 3. false Biostage, Inc. /s/ Thomas McNaughton Thomas McNaughton Chief Financial Officer 2018-06-05